EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Integrative Computational Approaches for Understanding Drug Resistance in HIV-1 Protease Subtype C

Sankaran Venkatachalam, Nisha Muralidharan, Ramesh Pandian iD, Yasien Sayed iD, M Michael Gromiha iD

Viruses · 2025

DOI: 10.3390/v17060850 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2025. Verfasst von Sankaran Venkatachalam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai 600036, India. Hauptthemen laut MEDLINE: Drug Resistance, Viral, HIV Protease, HIV-1, HIV Protease Inhibitors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acquired immunodeficiency syndrome (AIDS) is a chronic disease condition caused by the human immunodeficiency virus (HIV). The widespread availability of highly active antiretroviral therapies has helped to control HIV. There are ten FDA-approved protease inhibitors (PIs) that are used as part of antiretroviral therapies in HIV treatment. Importantly, all these drugs are designed and developed against the protease (PR) from HIV subtype B. On the other hand, HIV-1 PR subtype C, which is the most dominant strain in countries including South Africa and India, has shown resistance to PIs due to its genetic diversity and varied mutations. The emergence of resistance is concerning because the virus continues to replicate despite treatment; hence, it is necessary to develop drugs specifically against subtype C. This review focuses on the origin, genetic diversity, and mutations associated with HIV-1 PR subtype C. Furthermore, computational studies performed on HIV-1 PR subtype C and mutations associated with its resistance to PIs are highlighted. Moreover, potential research gaps and future directions in the study of HIV-1 PR subtype C are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, ViralHIV ProteaseHIV-1HIV Protease InhibitorsComputational BiologyHumansMutationHIV InfectionsGenetic Variation

Stichwörter der Autor:innen

AIDSHIV proteaseMD simulationscomputational studiesinsertionmutationstructure activity relationshipsubtype C

Substanzen

HIV ProteaseHIV Protease Inhibitorsp16 protease, Human immunodeficiency virus 1

Autor:innen und Institutionen

  • Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai 600036, India.
  • Protein Structure-Function Research Laboratory, School of Molecular and Cell Biology, University of the Witwatersrand, Johannesburg 2000, South Africa.

ORCID-Profile: Ramesh Pandian, Yasien Sayed, M Michael Gromiha

Förderung

  • Department of Science and Technology

Zitieren

APA

Venkatachalam, S., Muralidharan, N., Pandian, R., Sayed, Y., & Gromiha, M. M. (2025). Integrative Computational Approaches for Understanding Drug Resistance in HIV-1 Protease Subtype C. Viruses. https://doi.org/10.3390/v17060850

Vancouver

Venkatachalam S, Muralidharan N, Pandian R, Sayed Y, Gromiha MM. Integrative Computational Approaches for Understanding Drug Resistance in HIV-1 Protease Subtype C. Viruses. 2025. doi:10.3390/v17060850

BibTeX
@article{Venkatachalam2025,
  author = {Venkatachalam, Sankaran and Muralidharan, Nisha and Pandian, Ramesh and Sayed, Yasien and Gromiha, M Michael},
  title = {Integrative Computational Approaches for Understanding Drug Resistance in HIV-1 Protease Subtype C},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17060850}
}
Kostenlos starten →